| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash provided by financing activities | 48,540 | 15,848 |
| Effect of foreign exchange rates on cash, cash equivalents, and restricted cash | 72 | 101 |
| Net (decrease) increase in cash, cash equivalents, and restricted cash | -105,824 | -93,573 |
| Cash and cash equivalents at beginning of period | 305,838 | - |
| Cash and cash equivalents at end of period | 200,014 | - |
Wave Life Sciences Ltd. (WVE)
Wave Life Sciences Ltd. (WVE)